Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

29452 ARTÍCULOS , VIENDO DEL 316 AL 330

Human Stem Cell-Derived Models of the Alzheimer's Disease Neuroimmune System

Summers RA, Quang D, Johnson NR.

Int J Mol Sci. 2026 Aug 18;27(16):7360. doi: 10.3390/ijms27167360.

High-intensity interval training versus mesenchymal stem cells in amyloid-β-induced Alzheimer's disease: comparative effects on cognitive function,hippocampal inflammation, oxidative balance, and BDNF

Hosseini MS, Saheli M, RajiZadeh MA, Nematollahi-Mahani SN, Joushi S, Gaeini A, Khoramipour K, Sheibani V.

Biochem Biophys Res Commun. 2026 Oct 8;834:154463. doi: 10.1016/j.bbrc.2026.154463. Epub 2026 Aug 19.

Neurobiological mechanisms of 40-Hz stimulation in Alzheimer's disease: evidence, heterogeneity, and constraints

Qi L, Wang W, Abdullah R, Zhao Y, Wang Z, Tang Y, Luo B, Peng G.

Alzheimers Dement. 2026 Sep;22(9):e71806. doi: 10.1002/alz.71806.

Mesenchymal Stem Cell-Derived Exosomes for Alzheimer's Disease: Mechanisms, Preclinical Evidence, and Translational Challenges

Bach DH, Hoang VT, Nguyen TL.

Mol Neurobiol. 2026 Sep 10;63(1):887. doi: 10.1007/s12035-026-06193-0.

Caenorhabditis elegans as a Model for Studying Nrf2/SKN-1 Activation in Alzheimer's Disease: Plant Bioactive Compounds and Therapeutic Translation

Bellver-Sanchis A, Ralchev NR, Romanska PR, Dyakova NK, Ivanova KI, Griñán-Ferré C, Marchev AS.

Int J Mol Sci. 2026 Sep 1;27(17):7833. doi: 10.3390/ijms27177833.

Unlocking the Potential of Isatin Scaffolds in Acetylcholinesterase Inhibition

Tharwat T, El-Nassan HB, Adly ME, Kamel MM.

Arch Pharm (Weinheim). 2026 Sep;359(9):e70336. doi: 10.1002/ardp.70336.

APOE ε4 variant interpretation and protein numbering discrepancy: a case report

Dagdelen B, Ozguncu C, Zamani AG, Arikoglu H.

Mol Biol Rep. 2026 Sep 22;53(1):1608. doi: 10.1007/s11033-026-12809-4.

Palliative care status for people with Alzheimer's disease in the Eastern Mediterranean region: a review

Rassouli M, Hashemi AH, Ashrafizadeh H.

Int J Palliat Nurs. 2026 Sep 2;32(9):409-429. doi: 10.12968/ijpn.2024.0059. Epub 2026 Sep 23.

Revisiting Alzheimer's Disease Through the Somatostatin-Mitochondria Axis

Liu K, Zhang XY, Qiu HB, Su CQ, Wang SY, Pei ZJ, Jin RH, Bing YH.

Mol Neurobiol. 2026 Sep 24;63(1):920. doi: 10.1007/s12035-026-06221-z.

A cell-type-resolved meta-analysis reveals glial DNA methylation changes associated with aging and Alzheimer's disease

Bhaskar U, Kos MZ, Carless MA.

Alzheimers Dement. 2026 Sep;22(9):e71864. doi: 10.1002/alz.71864.

Clinical Validation of Plasma p-217tau in Neurological Diseases

Kawarabayashi T, Nakamura T, Takahashi R, Ueda T, Kinoshita S, Uchida C, Sugawara T, Hashimoto K, Ishizawa K, Amari M, Kasahara H, Ikeda Y, Takatama M, Shoji M.

Ann Clin Transl Neurol. 2026 Sep;13(9):1780-1790. doi: 10.1002/acn3.70359. Epub 2026 Mar 9.

Enhancing brain delivery of tegaserod for Alzheimer's disease: a pharmaceutical comparison of two nanocarrier-based strategies

Séguy L, Guyon L, Corvaisier S, Maurel M, Verdié P, Herbinet R, Pluart LL, Dehouck L, Sevin E, Fenart L, Gosselet F, Lagadu S, Née G, Fréret T, Since M, Delépée R, Dallemagne P, Lisowski V, Groo AC, Malzert-Fréon A.

Int J Pharm. 2026 Sep 5;702:127181. doi: 10.1016/j.ijpharm.2026.127181. Epub 2026 Jul 15.

From viral epigenetic reprogramming to neuroinflammation: Mechanisms driving neurodegeneration

Vora C, Saini V, Shevtsov M, Trivedi P, Sonawane A, Jha HC.

J Neurovirol. 2026 Aug 27;32(5):40. doi: 10.1007/s13365-026-01341-7.

Protein Aggregates as Drivers of Receptor Clustering and Pathological Signaling: A Framework Linking Extracellular Amyloid-β to Tau Dysregulation

Ratis RC, Bonini JS, Bold ABW.

ACS Chem Neurosci. 2026 Sep 2;17(17):3150-3155. doi: 10.1021/acschemneuro.6c00331.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias